New Global Guideline Reframes Obesity As A Driver Of Diabetes, Kidney And Heart Disease: Lessons For India

In a significant shift in the understanding of obesity and its health consequences, leading US medical bodies have released the first-ever clinical guideline on what is known as cardiovascular-kidney-metabolic (CKM) syndrome, recognising excess body fat as a common driver of diabetes, chronic kidney disease (CKD), heart attacks, strokes and heart failure.

The guideline, jointly issued by the American Heart Association (AHA) and the American College of Cardiology (ACC), comes at a time when India is grappling with a rapidly growing burden of obesity-linked diseases.

The new framework marks a departure from the traditional approach that viewed obesity largely as a matter of body weight or lifestyle. Instead, it identifies obesity as a chronic disease capable of triggering damage across multiple organ systems long before symptoms become apparent.

For India, the implications are substantial. The country is home to more than 100 million people living with diabetes, while cardiovascular diseases remain the leading cause of mortality. Simultaneously, cases of obesity, fatty liver disease and CKDs are rising across both urban and semi-urban populations, driven by sedentary lifestyles, unhealthy diets and changing patterns of work and recreation.

The guideline argues that these conditions should no longer be viewed in isolation.

“People and healthcare professionals treat these conditions separately, but they’re deeply connected. For the first time, a clinical guideline addresses the connection,” the organisations noted.

According to the recommendations, excess fat—particularly abdominal fat that accumulates around internal organs—can trigger chronic inflammation, insulin resistance and metabolic dysfunction. Over time, these changes damage blood vessels and vital organs, increasing the risk of diabetes, kidney disease, heart attacks, strokes and heart failure.

“In terms of CKM health, weight is not just about a number on a scale—people with the same body weight can have very different health profiles,” said Dr. Chiadi E. Ndumele, Director of Obesity and Cardiometabolic Research at Johns Hopkins University and chair of the guideline writing committee.

“Rather, what’s most important is how fat tissue affects your metabolic health. This includes how your body manages blood sugar levels and how fat is used and stored,” he said.

The guideline replaces earlier obesity-management recommendations that largely focused on weight reduction alone. The new approach emphasises assessing the broader impact of excess fat on blood sugar, cholesterol levels, blood pressure, kidney function and cardiovascular health.

Health experts say this perspective is especially important in India because South Asians often develop metabolic complications at lower body mass indices than Western populations. Many individuals who appear only moderately overweight may already be at elevated risk of diabetes and cardiovascular disease.

“Maintaining a healthy weight has long been seen as essential to heart health and preventing other chronic illness. However, doctors don’t always raise the topic of weight unless a patient brings it up, and often the focus is on appearance rather than health,” said Dr. Ambar Kulshreshtha, a primary care physician and member of the guideline writing group.

The guideline encourages clinicians to initiate conversations about weight as a medical risk factor rather than a matter of appearance. Experts note that obesity-related inflammation can gradually impair the body's ability to regulate blood sugar, damage blood vessels and reduce kidney function, often for years before serious disease becomes evident.

The guideline advocates earlier screening and intervention through lifestyle modification, regular monitoring and appropriate medical therapy to prevent progression to advanced disease.

To explain the interconnected nature of CKM syndrome, Dr. Kulshreshtha compares the body's circulatory system to a network of household pipes.

Obesity-driven inflammation, he said, acts like rust gradually building up inside the system. Over time, that damage affects blood vessels, weakens the heart and reduces the kidneys' ability to function effectively.

The result is a cascade of interconnected illnesses that frequently require lifelong treatment and repeated hospitalisation.

The guideline also calls for greater coordination among healthcare providers. Patients with obesity often consult endocrinologists for diabetes, cardiologists for heart disease and nephrologists for kidney problems, with each specialist focusing primarily on one aspect of the illness.

To bridge these gaps, the recommendations support the use of care coordinators or navigators who can help integrate treatment across specialties and ensure continuity of care.

“People appreciate being seen and treated holistically,” said Dr. Fatima Rodriguez, Chief of Preventive Cardiology at Stanford University and vice-chair of the writing committee. “The idea is that patient care is a team effort, and the patient is team captain.”

The guideline also highlights the importance of addressing broader social determinants of health, including access to nutritious food, opportunities for physical activity and affordable healthcare services.

As Dr. Ndumele noted, the objective is not merely to manage disease after it develops but to intervene early enough to prevent damage to the heart, kidneys and metabolic system.